Thomas Reed is a Orange, California based psychiatrist who is specialized in Child & Adolescent. Active license number of Thomas Reed is A031313 for Child & Adolescent in California. His current practice location is 331 City Dr. South, Orange. Patients can reach him at 714-935-6363 or can fax him at 714-935-8112. Thomas Reed NPI number (Unique professional ID assigned by NPPES) is 1578582821. Thomas Reed has done additional skills and training in the diagnosis and treatment of developmental, behavioral, emotional, and mental disorders of childhood and adolescence.
Complete Profile:
Thomas Reed speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Thomas Reed
Specialization:
Child & Adolescent
Gender:
Male
Practice Address:
331 City Dr. South, Orange, California, 92863
Phone:
714-935-6363
Fax:
714-935-8112
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1578582821
NPI Enumeration Date:
18 Jul, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Thomas Reed are as mentioned below.
License Number
Specialization
State
Status
A031313
Child & Adolescent
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Thomas Reed Cegu, Po Box 7244 Orange, California
Zip:
92863
Patients can reach Thomas Reed at 331 City Dr. South, Orange, California or can call to book an appointment on 714-935-6363.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.